Basically packaging segment is full commodity in nature Globally, what ever you try to establish as a premium it’s not, Moldtk main revenue is paint segment where many player has appeared & margin of profit may shrink as everyone will lure Dealer with that, so shifting to expensive packaging quickly is really doubtful, also policy change in USA in pharma segment may boost sentiment but actual demand tick may take time, that’s why it’s in a consolidation mode for long & will be, also some broking house pump it & over ownership has been created, but fundamentally a good stock with uncertainties
Subscribe To Our Free Newsletter |